Vertrauenswert 8/100
Professor Andrew John Davies
👤 2 Jahre Erfahrung
2,341+
Patients seen
2
Years in practice
13
Publications
1
Languages spoken
Über uns
Andrew Davies is Professor of Haematological Oncology in the Cancer Sciences Unit in
the Faculty of Medicine, University Hospital Southampton. He completed his
training in Medical Oncology at St Bartholomew’s Hospital in London, and as a
Cancer Research UK clinical fellow he undertook a PhD examining the molecular
mechanisms underlying transformation of follicular lymphoma to more aggressive
histological sub-types.
Prof. Davies specialises in the treatment of malignant lymphoma. He has a particular
interest in the investigation of monoclonal antibody-containing therapies and
other novel therapeutics applied to lymphoma. His work also focuses on translation
of biomarkers and novel therapies to the clinical arena. He has extensive experience in early phase
trials, including leading several first in man lymphoma studies all the way
through to leading late phase studies.
He
is Chair of the UK National Cancer Research Institute Lymphoma Research Groups
and past Chair of the High Grade Lymphoma Study Group. He is Director of the Cancer
Research UK/National Institute of Health Southampton Experimental Cancer
Medicine Centre. He is also the Wessex regional lead for cancers in Teenagers
and Young Adults (TYA) and Clinical Lead for the Thames Valley and Wessex TYA
Operational Delivery Network
the Faculty of Medicine, University Hospital Southampton. He completed his
training in Medical Oncology at St Bartholomew’s Hospital in London, and as a
Cancer Research UK clinical fellow he undertook a PhD examining the molecular
mechanisms underlying transformation of follicular lymphoma to more aggressive
histological sub-types.
Prof. Davies specialises in the treatment of malignant lymphoma. He has a particular
interest in the investigation of monoclonal antibody-containing therapies and
other novel therapeutics applied to lymphoma. His work also focuses on translation
of biomarkers and novel therapies to the clinical arena. He has extensive experience in early phase
trials, including leading several first in man lymphoma studies all the way
through to leading late phase studies.
He
is Chair of the UK National Cancer Research Institute Lymphoma Research Groups
and past Chair of the High Grade Lymphoma Study Group. He is Director of the Cancer
Research UK/National Institute of Health Southampton Experimental Cancer
Medicine Centre. He is also the Wessex regional lead for cancers in Teenagers
and Young Adults (TYA) and Clinical Lead for the Thames Valley and Wessex TYA
Operational Delivery Network
“Evidence-based care tailored to each patient — taking the time to explain options and shared decisions.”
— Professor Andrew John Davies
Ausbildung & Training
-
2014–2020 MD · Medicine and Surgery
-
2020–2024 Residency · Onkologie
Karriere & Anstellungen
-
2024-09–2025-08 Junior consultant
Lizenzen & Versicherung
Medizinische Lizenzen
GB — Organización Médica Colegial de España (OMC)
Facharztzertifikate
European Board of Onkologie
Berufshaftpflichtversicherung:
HDI Global · 4,000,000 EUR Deckung · No claims on file
Durchgeführte Verfahren
| Verfahren | Code | Lebenszeit-Anzahl |
|---|---|---|
| GP consultation | 99213 | 485 |
| Annual physical exam | 99395 | 275 |
| Vaccination administration | 90471 | 1,859 |
| Minor procedure (skin) | 17110 | 596 |
Leistungen & Preise
| Leistung | Dauer | Modalität | Preis |
|---|---|---|---|
| New patient consultation (60m) | 60 Min. | in_clinic|telemed | 180.00 EUR |
| Follow-up consultation (30m) | 30 Min. | in_clinic|telemed|phone | 90.00 EUR |
| Vaccination administration | 30 Min. | in_clinic | 180.00 EUR |
| Minor procedure (skin) | 120 Min. | in_clinic | 450.00 EUR |
Praxis, Team & in der Praxis
Videos
Forschung & Publikationen
h-Index: 6 · i10: 9
-
Validation of clinical scoring in Onkologie
DOI: 10.9397/euroclin.2026.0 · PMID: 38476587 · zitiert von 181
-
Long-term follow-up of Onkologie across GB
DOI: 10.4077/euroclin.2025.1 · PMID: 37640225 · zitiert von 175
-
Validation of clinical scoring in Onkologie
DOI: 10.3304/euroclin.2024.2 · PMID: 39009386 · zitiert von 25
-
Long-term follow-up of Onkologie across GB
DOI: 10.1966/euroclin.2023.3 · PMID: 39559839 · zitiert von 107
Eingeladene Vorträge
- Practical updates in Onkologie European Annual Congress (Onkologie) · Vienna · 2024 · invited
- Single-centre experience in Onkologie National Society Meeting · Southampton · 2023 · oral abstract
Auszeichnungen & Mitgliedschaften
Auszeichnungen
- 🏆 Top-rated Onkologie — Southampton · EuroClinics Patient Choice · 2025 · regional
Gesellschaftsmitgliedschaften
- WONCA Europe — Family Doctors — Member · Seit 2025
- national college of family doctors — Member · Seit 2025
- European Union of Medical Specialists (UEMS) — Member · Seit 2025
Artikel dieses Arztes
- Patient education Patient guide to Onkologie
- Awareness When should you see a onkologie?
Für internationale Patienten
- Koordinator
- Patient liaison · andrew.john.davies@euroclinics.example
Standort
1 TagPatientenbewertungen
Teilen Sie Ihre Erfahrung — Helfen Sie anderen Patienten, den richtigen Arzt zu finden. Bewertung schreiben →
Aktuelle Bewertungen
-
★★★★★ ✓ Verifiziert Very thorough first visit — explained every step. Booking was easy and the staff were welcoming.
-
★★★★★ ✓ Verifiziert Took time to listen and reviewed all my previous results. I would absolutely recommend.
-
★★★★☆ ✓ Verifiziert Professional and knowledgeable. Wait on the day was a bit long, otherwise excellent.
Ähnliche Spezialisten
Alle durchsuchen →
Mr Abdulla Alhasso
Onkologie · Glasgow
Dr Alexander McDonald
Onkologie · Glasgow
Dr Amna Sheri
Onkologie · London
Dr Angus Robinson
Onkologie · Horley
Dr Anne Armstrong
Onkologie · Manchester
Dr Ashraf Azzabi
Onkologie · Washington
Dr Clare Green
Onkologie · Winchester
Dr Desmond Yip
Onkologie · Garran